Code: MTA9761 | Publication Date: Oct 2025 |
There are numbers of factors which are contributing in the expansion of the market include rising prevalence of cancer in companion animals, growing awareness among pet owners regarding advanced cancer treatments, increasing veterinary healthcare expenditure, and advancements in diagnostic and therapeutic technologies for animal oncology.
Veterinary Oncology Market is witnessing major growth with notable trends such as increasing adoption of targeted cancer therapies and immunotherapies for pets. More veterinary practices are using advanced diagnostic tools like MRI, CT scans, and molecular imaging. People are becoming more interested in minimally invasive oncology procedures that can help improve treatment outcomes.
Veterinary clinics are using digital health platforms to help with cancer consultations and monitoring. The market is changing due to more people are focusing on precision medicine and cancer detection based on biomarkers. The move toward combination therapies in veterinary oncology is also increasing.
Veterinary Oncology Market is evolving with rising R&D investments in novel oncology drugs, biologics, and gene therapies for animals. Advancements in radiation therapy equipment tailored for veterinary use are expanding treatment possibilities. More veterinary hospitals, research institutes, and drug companies are working together.
And more cancer vaccines are being made for pets to stop the disease from coming back. Tele-oncology services are becoming more common, allowing people to get care and consultations from a distance. The market is also seeing new ways to deliver drugs to animals and personalized cancer treatments, which are helping to improve treatment outcomes.
Some of the leading companies include: